KAMADA LTD. : Kamada Announces New Data on its Glassia Drug Supporting ... 4-traders Based on the results, Kamada reports that its AAT protein is modulating the activity of type B lymphocytes and by that enables the avoidance of organ transplant rejection and raises the likelihood for the transplant success. Furthermore, the results ... |
